For example, by dephosphorylating the phosphorylated tyrosine of the insulin receptor, PTP1B is able to block the activated insulin receptor pathway, as validated by PTP1B gene deficient mice showing enhanced insulin sensitivity and a decreased incidence of obesity and diabetes [6]. This evidence concerns the gene INS and obesity disorder.